WallStreetZenWallStreetZen

NASDAQ: OBX
Obsidian Therapeutics Inc Stock Ownership - Who owns Obsidian Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Obsidian Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when OBX insiders and whales buy or sell their stock.

OBX Shareholders

What type of owners hold Obsidian Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Matthew Norkunas0.05%30,937$850.77kInsider

1 of 1

OBX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABVC3.14%80.87%
ABVX63.37%0.00%
ACET28.27%71.73%Net Buying
ACXP4.23%59.85%
AARD46.75%46.87%Net Buying
View Top Biotech Stocks

Obsidian Therapeutics Stock Ownership FAQ

Who owns Obsidian Therapeutics?

Obsidian Therapeutics (NASDAQ: OBX) is owned by 0.00% institutional shareholders, 0.05% Obsidian Therapeutics insiders, and 99.95% retail investors. Matthew Norkunas is the largest individual Obsidian Therapeutics shareholder, owning 30,937.00 shares representing 0.05% of the company. Matthew Norkunas's Obsidian Therapeutics shares are currently valued at $1.08M.

If you're new to stock investing, here's how to buy Obsidian Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.